Obesity-induced ED is associated with decreased NO production due to impaired endothelial NO synthase activity and expression and increased production of superoxide anion and the endogenous NOS inhibitor ADMA, together with increased vasoconstrictor factors, such as endothelin-1 and sympathetic nerve activation [116]. This evidence concerns the gene EDN1 and obesity disorder.